Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
39.77
+0.09 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
40.00
+0.23 (0.58%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Soleno Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 70.11 | 87.93 | 169.68 | 14.6 | 21.3 | Upgrade
|
| Short-Term Investments | 235.37 | 203.51 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 305.47 | 291.44 | 169.68 | 14.6 | 21.3 | Upgrade
|
| Cash Growth | 4.82% | 71.76% | 1062.04% | -31.46% | -56.72% | Upgrade
|
| Accounts Receivable | 28.21 | - | - | - | - | Upgrade
|
| Receivables | 28.21 | - | - | - | - | Upgrade
|
| Inventory | 15.02 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 7.11 | 2.45 | 1.68 | 1.05 | 1.12 | Upgrade
|
| Total Current Assets | 355.81 | 293.89 | 171.36 | 15.65 | 22.42 | Upgrade
|
| Property, Plant & Equipment | 2.38 | 2.98 | 0.42 | 0.16 | 0.45 | Upgrade
|
| Long-Term Investments | 200.62 | 27.21 | - | - | - | Upgrade
|
| Other Intangible Assets | 4.86 | 6.81 | 8.75 | 10.69 | 12.64 | Upgrade
|
| Other Long-Term Assets | 0.16 | 0.08 | 0.17 | - | 0.04 | Upgrade
|
| Total Assets | 563.83 | 330.97 | 180.69 | 26.5 | 35.55 | Upgrade
|
| Accounts Payable | 12.44 | 8.88 | 3.15 | 1.78 | 3.25 | Upgrade
|
| Accrued Expenses | 27.82 | 9.34 | 6.53 | 4.9 | 4.15 | Upgrade
|
| Current Portion of Leases | 0.73 | 0.53 | 0.27 | 0.16 | 0.28 | Upgrade
|
| Other Current Liabilities | 20.38 | - | 1.56 | 0.48 | 0.32 | Upgrade
|
| Total Current Liabilities | 61.36 | 18.75 | 11.51 | 7.31 | 8.01 | Upgrade
|
| Long-Term Debt | 49.86 | 49.83 | - | - | - | Upgrade
|
| Long-Term Leases | 1.96 | 2.47 | 0.13 | - | 0.18 | Upgrade
|
| Other Long-Term Liabilities | 0.53 | 14.81 | 11.55 | 8.84 | 9.58 | Upgrade
|
| Total Liabilities | 113.72 | 85.86 | 23.18 | 16.15 | 17.76 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.03 | 0.01 | 0.08 | Upgrade
|
| Additional Paid-In Capital | 881.02 | 696.97 | 433.89 | 247.76 | 231.07 | Upgrade
|
| Retained Earnings | -431.37 | -452.26 | -276.41 | -237.42 | -213.36 | Upgrade
|
| Comprehensive Income & Other | 0.42 | 0.36 | - | - | - | Upgrade
|
| Total Common Equity | 450.12 | 245.11 | 157.51 | 10.35 | 17.79 | Upgrade
|
| Shareholders' Equity | 450.12 | 245.11 | 157.51 | 10.35 | 17.79 | Upgrade
|
| Total Liabilities & Equity | 563.83 | 330.97 | 180.69 | 26.5 | 35.55 | Upgrade
|
| Total Debt | 52.55 | 52.83 | 0.4 | 0.16 | 0.46 | Upgrade
|
| Net Cash (Debt) | 453.54 | 265.82 | 169.28 | 14.45 | 20.85 | Upgrade
|
| Net Cash Growth | 70.62% | 57.03% | 1071.72% | -30.70% | -57.52% | Upgrade
|
| Net Cash Per Share | 8.66 | 6.62 | 10.26 | 1.72 | 3.92 | Upgrade
|
| Filing Date Shares Outstanding | 51.62 | 45.86 | 32.46 | 8.17 | 5.34 | Upgrade
|
| Total Common Shares Outstanding | 52.29 | 45.7 | 31.68 | 8.16 | 5.32 | Upgrade
|
| Working Capital | 294.45 | 275.14 | 159.85 | 8.33 | 14.42 | Upgrade
|
| Book Value Per Share | 8.61 | 5.36 | 4.97 | 1.27 | 3.34 | Upgrade
|
| Tangible Book Value | 445.25 | 238.31 | 148.76 | -0.35 | 5.16 | Upgrade
|
| Tangible Book Value Per Share | 8.52 | 5.21 | 4.70 | -0.04 | 0.97 | Upgrade
|
| Machinery | 0.22 | 0.2 | 0.1 | 0.1 | 0.1 | Upgrade
|
| Leasehold Improvements | 0.09 | 0.05 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.